A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

NCT00189813 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
691
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astellas Pharma Inc

Collaborators